Clinical trial Recruiting at 1 site Interventional Ages 7 to 12

Using a kaleidoscope to reduce pain in children with burn injuries

Official title: Distraction as Treatment for Pain in Children in Resource-scarce Settings

Run by Vrinnevi Hospital · NCT06933303 · Data updated 2026-11-12

This study tests if using a kaleidoscope can help reduce pain for kids aged 7-12 with burn injuries during their dressing changes.

More Pain, Acute trials

Quick facts

Study typeInterventional
Ages7 Years to 12 Years
SexAll
Enrollment126 (estimated)
SponsorVrinnevi Hospital
Academic / other
Locations1 site (Empangeni, KwaZulu-Natal)
StatusRecruiting
StartedMarch 30, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 18, 2025
Trial IDNCT06933303 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric patients aged 7-12 years with partial thickness burn injuries requiring dressing changes.

Probably not a fit

Patients with severe burn injuries, those receiving pain medication, or those with impairments that prevent the use of a kaleidoscope may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a non-electronic distraction method, specifically a kaleidoscope, to alleviate acute pain in pediatric patients aged 7-12 years undergoing dressing changes for partial thickness burn injuries. Conducted in resource-scarce settings, the randomized controlled trial will compare the pain levels of children using the kaleidoscope against a control group receiving standard care without distraction. The aim is to provide a simple, cost-effective tool for pain management in environments where medication and advanced equipment are limited.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management for children in low-resource settings during medical procedures.

How similar studies have gone: While distraction techniques have been used in various settings, this specific approach using a kaleidoscope in resource-scarce environments is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients between the age of 7 and 12 years old with burn injuries requiring dressing changes in the outpatient clinic, who in regular practice (non-research setting) would not receive any analgesics;
* Type of burn injury: partial thickness burns with a burned area not greater than 10% at the moment of the first dressing change measurement as part of this research

Exclusion Criteria:

* Patients who received split skin grafts for their burns;
* Patients on sedatives or anti-epileptics;
* The use of pain-relieving medication other than paracetamol or ibuprofen;
* Painful additional injuries other than the burn injury;
* Patients who are nursed in isolation;
* Physical or mental impairments which make it impossible to adequately comply with the trial protocol. For example, visual impairments, impaired ability to communicate, psychological comorbidities, and burns that limit the use of a kaleidoscope (facial burns or burns to both hands);
* Retrospective exclusion if the patient in the intervention group did not look through the kaleidoscope for more than 50% of the procedure time.

Where it's running

  • Ngwelezana Hospital
    Empangeni, KwaZulu-Natal, South Africa
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.